Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Age-related Correlates of Treatment for Late-acquired Sounds (ARC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03663972
Recruitment Status : Completed
First Posted : September 10, 2018
Last Update Posted : June 18, 2020
Sponsor:
Information provided by (Responsible Party):
Breanna Irene Krueger, University of Wyoming

Brief Summary:
Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes.

Condition or disease Intervention/treatment Phase
Speech Sound Disorder Phonology Disorder Phonology Impairment Phonological Disorder Articulation Disorders in Children Developmental Phonological Disorder Speech Disorders Speech Delay Articulation Disorders, Developmental Behavioral: articulation therapy Behavioral: phonologic treatment Not Applicable

Detailed Description:
Late-acquired sounds, such as /r/ are difficult to learn and many children experience persistent errors on these sounds. However, these sounds are often treated later in a child's life because they are not expected to be fully acquired until quite late--age 7-8 for some sounds. This practice places treatment in a time of the child's development in which they struggle to learn new sounds.The purpose of the present study is to determine whether treating these sounds earlier in the child's life may result in better outcomes, and to examine treatment efficacy and efficiency for two methods of treatment.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 16 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Young children (age 4-5) and Old children (age 7-8) will be enrolled in either a Motoric behavioral treatment arm or phonological treatment arm.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Age-related Correlates of Treatment Efficacy and Efficiency for Late-acquired Sounds
Actual Study Start Date : June 11, 2018
Actual Primary Completion Date : April 30, 2020
Actual Study Completion Date : April 30, 2020

Arm Intervention/treatment
Active Comparator: Motoric Arm
Children will participate in an intervention based on traditional articulation approaches to speech therapy.
Behavioral: articulation therapy
children receive instruction in producing new sounds at the isolation, syllable and word level.

Active Comparator: Phonologic Arm
Children will receive intervention that targets the conceptual representation of sounds.
Behavioral: phonologic treatment
children receive instruction in producing new sounds at the word level




Primary Outcome Measures :
  1. Treatment Efficacy: Number of correct productions of treated speech sounds in treatment words [ Time Frame: baseline until accuracy criterion is met; up to 18 weeks after final baseline session ]
    Accurate Production of treatment sound at baseline and at posttest

  2. Treatment Efficiency: Number of sessions required to meet accuracy criteria [ Time Frame: baseline until accuracy criterion is met; up to 18 weeks after final baseline session ]
    Number of treatment sessions required to meet accuracy criteria (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions)

  3. Session Length: Mean duration of sessions in minutes [ Time Frame: First treatment session until final treatment session. Final treatment session occurs when accuracy of treatment sound is met (90% accuracy across three consecutive sessions or a maximum of 35 treatment sessions) ]
    Start and end time of session is recorded on scoresheet, then number of minutes for each session for each participant is found and the mean across all sessions is calculated.


Secondary Outcome Measures :
  1. Accuracy of production of untreated sounds measured on pretest and posttest probes [ Time Frame: baseline and at posttest up to 18 weeks after final baseline session ]
    Some children may generalize their skills learned through treatment to sounds that were not treated in the trial.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years to 8 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusionary Criteria:

  • Normal Hearing
  • Typical Receptive Language
  • Speech Sound Disorder
  • No motor speech impairment
  • Typical non-verbal intelligence
  • Produces at least one late-acquired sound with <7% accuracy
  • Monolingual English-speaking
  • Typical in terms of motoric and neurological development

Exclusionary Criteria:

  • Neurological disorder
  • Hearing loss
  • Nonverbal IQ < 16th percentile

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03663972


Locations
Layout table for location information
United States, Wyoming
University of Wyoming
Laramie, Wyoming, United States, 82071
Sponsors and Collaborators
University of Wyoming
Investigators
Layout table for investigator information
Principal Investigator: Breanna I. Krueger, PhD University of Wyoming
Layout table for additonal information
Responsible Party: Breanna Irene Krueger, Assistant Professor, University of Wyoming
ClinicalTrials.gov Identifier: NCT03663972    
Other Study ID Numbers: 20180510BK01978
First Posted: September 10, 2018    Key Record Dates
Last Update Posted: June 18, 2020
Last Verified: June 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Breanna Irene Krueger, University of Wyoming:
treatment
efficacy
efficiency
late-acquired sounds
Additional relevant MeSH terms:
Layout table for MeSH terms
Speech Disorders
Articulation Disorders
Language Development Disorders
Disease
Speech Sound Disorder
Pathologic Processes
Language Disorders
Communication Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Neurodevelopmental Disorders
Mental Disorders